Furosemide

InterventionApproved 1966

1 paper studies it7 more mention it

PubChemChEBIMeSH

  • 139 trials, none about aging, 61 with no results posted
  • Humans1

Trials

0 about aging, of 139

Approved

  • FDA Lasix

    Jul 1, 1966DiscontinuedEdema, Hypertension, Nephrotic Syndrome, Congestive Heart Failure, renal disease, cirrhosis of the liver

  • FDA Lasix

    Mar 20, 1968Discontinued

  • FDA Lasix

    Mar 8, 1977Discontinued

  • FDA Furosemide

    Jan 10, 1979Discontinued

  • FDA Furosemide

    May 19, 1981Edema, Heart Failure, Nephrotic Syndrome, Pulmonary Edema, renal disease, cirrhosis of the liver

  • FDA Furosemide

    Aug 27, 1981Discontinued

All 27

Repurposing

40 of 64

In trials

  • Pregnancy-Induced Hypertension

    Phase 4Terminated4 trials

  • Bronchiolitis

    Phase 3Completed2 trials

  • Transient Tachypnea of the Newborn

    Phase 3Completed2 trials

  • Cutaneous Warts

    Phase 2Completed2 trials

  • Respiratory distress syndrome

    Phase 2Results posted2 trials

Stopped

  • NCT02458157TerminatedEdema

    Very low recruitment rates

  • NCT03731117TerminatedAcute kidney injury

    Study end date exceeded and insufficient number of subjects needed for analysis. 11 patients included / 70 theoretical patients

  • NCT05158153TerminatedAcute kidney injury

    Inadequate recruitment

  • NCT04343235TerminatedPregnancy-Induced Hypertension

    Challenges with enrollment; primary investigator left the institution

  • NCT03170219TerminatedAcute heart failure

    Slow enrollment

  • NCT03362515TerminatedNasal polyps

    The study was terminated prematurely due to low enrollment numbers and the development of better drugs to treat polyps (ie. Biologics) which were not available when the study began.

All 7

Trial sponsors

Latest

Nov 2025: 3Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 05 papers in 12 months